Free Trial

Cardiol Therapeutics (CRDL) SEC Filings & 10K Form

Cardiol Therapeutics logo
$1.20 -0.10 (-7.69%)
Closing price 04:00 PM Eastern
Extended Trading
$1.25 +0.05 (+3.75%)
As of 07:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cardiol Therapeutics SEC Filings

DateFilerForm TypeView
02/20/2025
7:21 AM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2025
7:40 AM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/18/2024
10:39 AM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
3:51 PM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2024
5:31 AM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/11/2024
1:20 PM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/10/2024
2:14 PM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/09/2024
3:26 PM
Cardiol Therapeutics (Filer)
Form SUPPL
10/09/2024
1:17 PM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/08/2024
4:10 PM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/08/2024
3:18 PM
Cardiol Therapeutics (Filer)
Form SUPPL
09/24/2024
6:38 AM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/10/2024
6:29 AM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/12/2024
4:00 PM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2024
11:15 PM
Cardiol Therapeutics (Filer)
Form EFFECT
07/16/2024
4:25 PM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2024
4:23 PM
Cardiol Therapeutics (Filer)
Form SUPPL
07/12/2024
2:20 PM
Cardiol Therapeutics (Filer)
Form F-10/A
07/05/2024
5:10 PM
Cardiol Therapeutics (Subject)
Form F-X
Appointment of agent for service of process and undertaking  
07/05/2024
4:18 PM
Cardiol Therapeutics (Filer)
Form F-10
Registration statement for securities of certain Canadian issuers  
06/25/2024
6:28 AM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/13/2024
6:59 AM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2024
10:43 AM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/14/2024
6:29 AM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/26/2024
7:10 AM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/26/2024
7:10 AM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2024
5:02 AM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/01/2024
4:15 PM
Cardiol Therapeutics (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/26/2024
9:06 AM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2024
6:29 AM
Cardiol Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CRDL) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners